Actionable news
0
All posts from Actionable news
Actionable news in TEVA: TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES,

Valeant: $50 Price Target Possible

The strong employment figures in the U.S. pushed all stocks higher. Biotech, the riskiest of assets, is rebounding too. Even Valeant Pharmaceuticals (VRX) stopped falling.

Do the growth prospects justify a $50 price target for the stock?

A 5Y EBITDA exit model assumes a drop in growth this fiscal year, followed by a rebound in the next four fiscal years. Valeant could survive a 15 percent drop in revenue growth this year and follow with at least 5 percent growth or higher through fiscal...


More